UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Harald zur Hausen (1936 to 2023): Discoverer of human papillomavirus infection as the main cause of cervical cancer

Proceedings of the National Academy of Sciences - PNAS, 2024-03, Vol.121 (11), p.e2400517121-e2400517121

Lowy, Douglas R

2024

Volltextzugriff (PDF)

HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions

The Journal of clinical investigation, 2016-01, Vol.126 (1), p.5-11

Lowy, Douglas R

2016

Volltextzugriff (PDF)

The Effect of Advances in Lung-Cancer Treatment on Population Mortality

The New England journal of medicine, 2020-08, Vol.383 (7), p.640-649

2020

Volltextzugriff (PDF)

Toward a Shared Vision for Cancer Genomic Data

The New England journal of medicine, 2016-09, Vol.375 (12), p.1109-1112

2016

Volltextzugriff (PDF)

The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment

Cell, 2021-04, Vol.184 (7), p.1661-1670

2021

Volltextzugriff (PDF)

Aiming High — Changing the Trajectory for Cancer

The New England journal of medicine, 2016-05, Vol.374 (20), p.1901-1904

2016

Volltextzugriff (PDF)

Understanding and learning from the success of prophylactic human papillomavirus vaccines

Nature reviews. Microbiology, 2012-10, Vol.10 (10), p.681-692

2012

Volltextzugriff (PDF)

An Introduction to Virus Infections and Human Cancer

Recent results in cancer research, 2021, Vol.217, p.1-11

2021

Volltextzugriff (PDF)

HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women

Cancer, 2008-11, Vol.113 (S10), p.3036-3046

2008

Volltextzugriff (PDF)

LD Motif Recognition by Talin: Structure of the Talin-DLC1 Complex

Structure (London), 2016-07, Vol.24 (7), p.1130-1141

2016

Volltextzugriff (PDF)

Reducing HPV-associated cancer globally

Cancer prevention research (Philadelphia, Pa.), 2012-01, Vol.5 (1), p.18-23

2012

Volltextzugriff (PDF)

Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial

JNCI : Journal of the National Cancer Institute, 2020-10, Vol.112 (10), p.1038-1046

2020

Volltextzugriff (PDF)

Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection

JAMA internal medicine, 2021-05, Vol.181 (5), p.672

2021

Volltextzugriff (PDF)

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

JNCI : Journal of the National Cancer Institute, 2011-10, Vol.103 (19), p.1444-1451

2011

Volltextzugriff (PDF)

Raising Expectations For Subunit Vaccine

The Journal of infectious diseases, 2015-05, Vol.211 (9), p.1373-1375

2015

Volltextzugriff (PDF)

Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging

The lancet oncology, 2015-05, Vol.16 (5), p.e226-e233

2015

Volltextzugriff (PDF)

Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica

PloS one, 2013-07, Vol.8 (7), p.e68329-e68329

2013

Volltextzugriff (PDF)

Carrageenan is a potent inhibitor of papillomavirus infection

PLoS pathogens, 2006-07, Vol.2 (7), p.e69-e69

2006

Volltextzugriff (PDF)

Prospects for preventing cancer with anti-microbial prophylactic vaccines

Cell host & microbe, 2023-01, Vol.31 (1), p.137-140

2023

Volltextzugriff (PDF)

Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment

American journal of obstetrics and gynecology, 2016-08, Vol.215 (2), p.212.e1-212.e15

2016

Volltextzugriff (PDF)

The COVID-19 Serology Studies Workshop: Recommendations and Challenges

Immunity, 2020-07, Vol.53 (1), p.1-5

2020

Volltextzugriff (PDF)

Strain-specific properties and T cells regulate the susceptibility to papilloma induction by Mus musculus papillomavirus 1

PLoS pathogens, 2014-08, Vol.10 (8), p.e1004314

2014

Volltextzugriff (PDF)

Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer

Cancer discovery, 2020-02, Vol.10 (2), p.288-305

2020

Volltextzugriff (PDF)

The expression of glyceraldehyde-3-phosphate dehydrogenase associated cell cycle (GACC) genes correlates with cancer stage and poor survival in patients with solid tumors

PloS one, 2013-04, Vol.8 (4), p.e61262-e61262

2013

Volltextzugriff (PDF)

Immunogenicity Testing in Human Papillomavirus Virus-Like-Particle Vaccine Trials

The Journal of infectious diseases, 2009-07, Vol.200 (2), p.166-171

2009

Volltextzugriff (PDF)

1 – 25 von 451

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(437)
Mit Volltextzugriff
(412)

Publikationsform

Sprache

Englisch
(451)

Erscheinungsjahr

n.n

Thema

Science & Technology
(306)
Life Sciences & Biomedicine
(254)
Humans
(249)
Animals
(153)
Female
(130)
Mice
(108)
Human Papillomavirus
(92)
Biological And Medical Sciences
(86)
Vaccines
(70)
Virology
(69)
Oncology
(68)
Adult
(63)
Papillomavirus Infections - Prevention & Control
(59)
Microbiology
(58)
Viruses
(56)
Fundamental And Applied Biological Sciences. Psychology
(52)
Multidisciplinary Sciences
(52)
Science & Technology - Other Topics
(52)
Cell Line
(51)
Immunology
(50)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Harald zur Hausen (1936 to 2023): Discoverer of human papillomavirus infection as the main cause of cervical cancer

HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions

The Effect of Advances in Lung-Cancer Treatment on Population Mortality

Toward a Shared Vision for Cancer Genomic Data

The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment

Aiming High — Changing the Trajectory for Cancer

Understanding and learning from the success of prophylactic human papillomavirus vaccines

An Introduction to Virus Infections and Human Cancer

HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women

LD Motif Recognition by Talin: Structure of the Talin-DLC1 Complex

Reducing HPV-associated cancer globally

Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial

Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

Raising Expectations For Subunit Vaccine

Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging

Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica

Carrageenan is a potent inhibitor of papillomavirus infection

Prospects for preventing cancer with anti-microbial prophylactic vaccines

Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment

The COVID-19 Serology Studies Workshop: Recommendations and Challenges

Strain-specific properties and T cells regulate the susceptibility to papilloma induction by Mus musculus papillomavirus 1

Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer

The expression of glyceraldehyde-3-phosphate dehydrogenase associated cell cycle (GACC) genes correlates with cancer stage and poor survival in patients with solid tumors

Immunogenicity Testing in Human Papillomavirus Virus-Like-Particle Vaccine Trials

Suchergebnisse filtern